OrthoPediatrics (KIDS) Plans Public Offering of Common Stock
Get Alerts KIDS Hot Sheet
Join SI Premium – FREE
OrthoPediatrics Corp. (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that it is commencing an underwritten public offering of its common stock. OrthoPediatrics and certain of its stockholders are proposing to sell shares of common stock, including shares to be offered by certain selling stockholders. OrthoPediatrics will not receive any proceeds from the sale of the shares by the selling stockholders. In addition, OrthoPediatrics intends to grant the underwriters a 30-day option to purchase additional shares of its common stock at the public offering price, less the underwriting discounts and commissions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.
OrthoPediatrics intends to use the net proceeds from the proposed offering to invest in implant and instrument sets for consignment to its customers, fund research and development activities, expand its sales and marketing programs and working capital and general corporate purposes.
Piper Jaffray and Stifel are acting as joint book-running managers and BTIG, JMP Securities and SunTrust Robinson Humphrey are acting as co-managers of the proposed offering.
The proposed offering will be made pursuant to a shelf registration statement on Form S-3 that became effective on November 9, 2018.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rithm Property Trust launches public stock offering
- Erasca, Inc (ERAS) files mixed shelf
- Autodesk establishes $2B commercial paper program
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Piper Jaffray, Stifel, JMP Securities, SunTrust Robinson Humphrey, S3, BTIGSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share